AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 30,650
-250 (-0.81%)
Last updated: Oct 2, 2025, 9:00 AM KST
AprilBio Revenue
AprilBio had revenue of 8.97B KRW in the twelve months ending June 30, 2025, down -56.67% year-over-year. In the year 2024, AprilBio had annual revenue of 27.51B.
Revenue (ttm)
8.97B
Revenue Growth
-56.67%
P/S Ratio
86.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
775.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.51B | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 200.00M | -23.20B | -99.15% |
| Dec 31, 2021 | 23.40B | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |